Azimuth Capital Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.36M | Sell |
21,032
-211
| -1% | -$93.9K | 0.35% | 106 |
|
|
2025
Q1 | $10.3M | Sell |
21,243
-898
| -4% | -$435K | 0.41% | 80 |
|
|
2024
Q4 | $8.92M | Buy |
22,141
+697
| +3% | +$281K | 0.35% | 98 |
|
|
2024
Q3 | $9.97M | Sell |
21,444
-105
| -0.5% | -$48.8K | 0.39% | 87 |
|
|
2024
Q2 | $10.1M | Sell |
21,549
-75
| -0.3% | -$35.2K | 0.41% | 72 |
|
|
2024
Q1 | $9.04M | Sell |
21,624
-20,421
| -49% | -$8.54M | 0.37% | 89 |
|
|
2023
Q4 | $17.1M | Sell |
42,045
-500
| -1% | -$203K | 0.77% | 42 |
|
|
2023
Q3 | $14.8M | Sell |
42,545
-584
| -1% | -$203K | 0.73% | 42 |
|
|
2023
Q2 | $15.2M | Sell |
43,129
-762
| -2% | -$268K | 0.72% | 42 |
|
|
2023
Q1 | $13.8M | Buy |
43,891
+108
| +0.2% | +$34K | 0.68% | 50 |
|
|
2022
Q4 | $12.6M | Buy |
43,783
+8,353
| +24% | +$2.41M | 0.64% | 49 |
|
|
2022
Q3 | $10.3M | Sell |
35,430
-147
| -0.4% | -$42.6K | 0.56% | 55 |
|
|
2022
Q2 | $10M | Buy |
+35,577
| New | +$10M | 0.51% | 65 |
|